Unresolved disorder model. using A ATOM 190 CG1AILE 22 4.303 5.361 25.476 0.54 10.26 C Unresolved disorder model. using A ATOM 191 CG1BILE 22 4.265 5.426 25.422 0.46 10.27 C Unresolved disorder model. using A ATOM 193 CD1AILE 22 3.457 6.554 25.126 0.54 11.23 C Unresolved disorder model. using A ATOM 194 CD1BILE 22 4.793 5.904 26.754 0.46 18.66 C Unresolved disorder model. using A ATOM 207 CE ALYS 24 11.252 -3.026 25.938 0.44 20.06 C Unresolved disorder model. using A ATOM 208 CE BLYS 24 11.011 -3.414 26.341 0.56 22.78 C Unresolved disorder model. using A ATOM 209 NZ ALYS 24 11.176 -4.417 26.449 0.44 25.03 N Unresolved disorder model. using A ATOM 210 NZ BLYS 24 12.482 -3.554 26.194 0.56 31.68 N Unresolved disorder model. using A ATOM 284 CB AASP 34 -8.601 -11.653 34.009 0.55 11.53 C Unresolved disorder model. using A ATOM 285 CB BASP 34 -8.572 -11.718 33.975 0.45 14.02 C Unresolved disorder model. using A ATOM 286 CG AASP 34 -8.861 -12.598 35.157 0.55 15.79 C Unresolved disorder model. using A ATOM 287 CG BASP 34 -8.703 -12.959 34.839 0.45 16.36 C Unresolved disorder model. using A ATOM 288 OD1AASP 34 -10.013 -13.023 35.367 0.55 15.30 O Unresolved disorder model. using A ATOM 289 OD1BASP 34 -8.267 -14.059 34.435 0.45 17.79 O Unresolved disorder model. using A ATOM 290 OD2AASP 34 -7.924 -12.974 35.900 0.55 22.14 O Unresolved disorder model. using A ATOM 291 OD2BASP 34 -9.257 -12.794 35.948 0.45 21.86 O Unresolved disorder model. using A ATOM 303 CB AHIS 36 -12.883 -14.343 37.335 0.65 19.83 C Unresolved disorder model. using A ATOM 304 CB BHIS 36 -12.770 -14.313 37.294 0.35 22.19 C Unresolved disorder model. using A ATOM 305 CG AHIS 36 -13.698 -15.434 36.668 0.65 24.98 C Unresolved disorder model. using A ATOM 306 CG BHIS 36 -13.402 -15.452 36.547 0.35 25.80 C Unresolved disorder model. using A ATOM 307 ND1AHIS 36 -15.027 -15.653 37.015 0.65 25.03 N Unresolved disorder model. using A ATOM 308 ND1BHIS 36 -12.906 -15.980 35.382 0.35 28.28 N Unresolved disorder model. using A ATOM 309 CD2AHIS 36 -13.420 -16.339 35.707 0.65 26.64 C Unresolved disorder model. using A ATOM 310 CD2BHIS 36 -14.525 -16.149 36.831 0.35 26.88 C Unresolved disorder model. using A ATOM 311 CE1AHIS 36 -15.523 -16.655 36.278 0.65 27.71 C Unresolved disorder model. using A ATOM 312 CE1BHIS 36 -13.697 -16.961 34.976 0.35 29.93 C Unresolved disorder model. using A ATOM 313 NE2AHIS 36 -14.563 -17.077 35.492 0.65 29.37 N Unresolved disorder model. using A ATOM 314 NE2BHIS 36 -14.692 -17.085 35.843 0.35 27.81 N Unresolved disorder model. using A ATOM 418 CB ASER 50 -25.459 8.401 17.860 0.64 16.81 C Unresolved disorder model. using A ATOM 419 CB BSER 50 -25.370 8.390 17.911 0.36 19.99 C Unresolved disorder model. using A ATOM 420 OG ASER 50 -26.045 8.236 19.147 0.64 18.56 O Unresolved disorder model. using A ATOM 421 OG BSER 50 -26.405 9.106 17.279 0.36 22.48 O Unresolved disorder model. using A ATOM 438 CB AASP 52 -28.894 7.108 12.365 0.58 21.29 C Unresolved disorder model. using A ATOM 439 CB BASP 52 -28.867 7.171 12.379 0.42 21.58 C Unresolved disorder model. using A ATOM 440 CG AASP 52 -29.999 7.202 11.348 0.58 20.38 C Unresolved disorder model. using A ATOM 441 CG BASP 52 -28.706 8.389 13.279 0.42 25.67 C Unresolved disorder model. using A ATOM 442 OD1AASP 52 -30.511 6.158 10.862 0.58 24.32 O Unresolved disorder model. using A ATOM 443 OD1BASP 52 -29.448 9.356 13.070 0.42 38.91 O Unresolved disorder model. using A ATOM 444 OD2AASP 52 -30.373 8.349 11.009 0.58 28.06 O Unresolved disorder model. using A ATOM 445 OD2BASP 52 -27.812 8.362 14.162 0.42 33.97 O Unresolved disorder model. using A ATOM 693 CB AASP 85 -16.115 13.019 30.073 0.55 21.16 C Unresolved disorder model. using A ATOM 694 CB BASP 85 -16.134 13.104 30.039 0.45 24.60 C Unresolved disorder model. using A ATOM 695 CG AASP 85 -15.902 14.496 30.140 0.55 26.97 C Unresolved disorder model. using A ATOM 696 CG BASP 85 -16.325 12.589 31.452 0.45 26.17 C Unresolved disorder model. using A ATOM 697 OD1AASP 85 -16.570 15.258 29.400 0.55 46.46 O Unresolved disorder model. using A ATOM 698 OD1BASP 85 -17.347 11.930 31.758 0.45 27.18 O Unresolved disorder model. using A ATOM 699 OD2AASP 85 -15.044 14.966 30.940 0.55 37.57 O Unresolved disorder model. using A ATOM 700 OD2BASP 85 -15.420 12.839 32.282 0.45 42.78 O Unresolved disorder model. using A ATOM 851 CG AGLN 103 -3.624 -16.925 14.902 0.62 12.56 C Unresolved disorder model. using A ATOM 852 CG BGLN 103 -3.746 -16.675 14.786 0.38 9.16 C Unresolved disorder model. using A ATOM 853 CD AGLN 103 -2.137 -17.320 15.032 0.62 18.21 C Unresolved disorder model. using A ATOM 854 CD BGLN 103 -2.513 -17.556 14.627 0.38 14.11 C Unresolved disorder model. using A ATOM 855 OE1AGLN 103 -1.753 -18.004 16.005 0.62 25.66 O Unresolved disorder model. using A ATOM 856 OE1BGLN 103 -2.524 -18.736 15.015 0.38 13.42 O Unresolved disorder model. using A ATOM 857 NE2AGLN 103 -1.328 -16.906 14.067 0.62 16.02 N Unresolved disorder model. using A ATOM 858 NE2BGLN 103 -1.454 -16.966 14.085 0.38 13.89 N Unresolved disorder model. using A ATOM 935 CE ALYS 113 -2.824 -15.551 20.991 0.52 14.29 C Unresolved disorder model. using A ATOM 936 CE BLYS 113 -2.923 -15.341 21.025 0.48 15.07 C Unresolved disorder model. using A ATOM 937 NZ ALYS 113 -2.454 -16.281 22.223 0.52 14.74 N Unresolved disorder model. using A ATOM 938 NZ BLYS 113 -1.714 -16.148 21.250 0.48 16.91 N Unresolved disorder model. using A ATOM 1213 CD ALYS 149 -18.479 -16.649 17.873 0.60 17.73 C Unresolved disorder model. using A ATOM 1214 CD BLYS 149 -18.449 -17.109 17.588 0.40 19.89 C Unresolved disorder model. using A ATOM 1215 CE ALYS 149 -18.769 -18.134 17.657 0.60 23.83 C Unresolved disorder model. using A ATOM 1216 CE BLYS 149 -19.954 -16.961 17.641 0.40 21.48 C Unresolved disorder model. using A ATOM 1217 NZ ALYS 149 -19.461 -18.613 18.899 0.60 29.54 N Unresolved disorder model. using A ATOM 1218 NZ BLYS 149 -20.507 -17.386 18.955 0.40 27.36 N Unresolved disorder model. using A ATOM 1336 CB ASER 166 -11.049 -2.791 -5.993 0.61 15.40 C Unresolved disorder model. using A ATOM 1337 CB BSER 166 -11.003 -2.698 -5.886 0.39 15.91 C Unresolved disorder model. using A ATOM 1338 OG ASER 166 -11.569 -2.251 -4.788 0.61 13.43 O Unresolved disorder model. using A ATOM 1339 OG BSER 166 -12.081 -3.186 -6.631 0.39 27.09 O Unresolved disorder model. using A ATOM 1370 CD ALYS 170 2.693 -0.170 1.931 0.55 17.91 C Unresolved disorder model. using A ATOM 1371 CD BLYS 170 2.720 -0.167 1.875 0.45 16.78 C Unresolved disorder model. using A ATOM 1372 CE ALYS 170 3.223 1.045 2.660 0.55 21.31 C Unresolved disorder model. using A ATOM 1373 CE BLYS 170 3.755 -0.446 0.804 0.45 20.70 C Unresolved disorder model. using A ATOM 1374 NZ ALYS 170 2.325 1.632 3.686 0.55 41.98 N Unresolved disorder model. using A ATOM 1375 NZ BLYS 170 5.143 -0.393 1.358 0.45 36.12 N Unresolved disorder model. using A ATOM 1502 CB AGLU 187 -27.882 -8.633 19.744 0.47 14.04 C Unresolved disorder model. using A ATOM 1503 CB BGLU 187 -28.048 -8.489 19.898 0.53 12.92 C Unresolved disorder model. using A ATOM 1504 CG AGLU 187 -29.258 -8.508 20.305 0.47 17.34 C Unresolved disorder model. using A ATOM 1505 CG BGLU 187 -28.774 -9.074 18.714 0.53 11.36 C Unresolved disorder model. using A ATOM 1506 CD AGLU 187 -29.814 -9.847 20.775 0.47 24.53 C Unresolved disorder model. using A ATOM 1507 CD BGLU 187 -29.527 -10.349 19.081 0.53 15.25 C Unresolved disorder model. using A ATOM 1508 OE1AGLU 187 -29.773 -10.847 20.031 0.47 28.03 O Unresolved disorder model. using A ATOM 1509 OE1BGLU 187 -29.637 -10.682 20.287 0.53 19.68 O Unresolved disorder model. using A ATOM 1510 OE2AGLU 187 -30.319 -9.901 21.909 0.47 32.64 O Unresolved disorder model. using A ATOM 1511 OE2BGLU 187 -30.013 -11.064 18.180 0.53 18.35 O Unknown residue CMH: ATOM 1657 N CMH 206 -3.520 7.357 24.556 1.00 7.21 N Unknown residue CMH: ATOM 1658 CA CMH 206 -4.595 8.325 24.408 1.00 7.29 C Unknown residue CMH: ATOM 1659 C CMH 206 -5.990 7.711 24.437 1.00 7.28 C Unknown residue CMH: ATOM 1660 O CMH 206 -6.980 8.441 24.268 1.00 9.05 O Unresolved disorder model. using A ATOM 1661 CB ACMH 206 -4.559 9.003 23.029 0.80 9.75 C Unknown residue CMH: ATOM 1661 CB CMH 206 -4.559 9.003 23.029 0.80 9.75 C Unresolved disorder model. using A ATOM 1662 CB BCMH 206 -4.382 9.178 23.154 0.20 9.32 C Unresolved disorder model. using A ATOM 1663 SG ACMH 206 -2.944 9.538 22.502 0.80 13.80 S Unknown residue CMH: ATOM 1663 SG CMH 206 -2.944 9.538 22.502 0.80 13.80 S Unresolved disorder model. using A ATOM 1664 SG BCMH 206 -4.112 8.272 21.622 0.20 10.30 S Unresolved disorder model. using A ATOM 1665 CM ACMH 206 -1.191 11.773 25.729 0.80 18.35 C Unknown residue CMH: ATOM 1665 CM CMH 206 -1.191 11.773 25.729 0.80 18.35 C Unresolved disorder model. using A ATOM 1666 HG ACMH 206 -2.061 10.758 24.308 0.80 15.87 HG Unknown residue CMH: ATOM 1666 HG CMH 206 -2.061 10.758 24.308 0.80 15.87 HG Unresolved disorder model. using A ATOM 1755 CB ASER 217 -21.071 -15.313 13.725 0.58 16.51 C Unresolved disorder model. using A ATOM 1756 CB BSER 217 -21.053 -15.315 13.838 0.42 15.96 C Unresolved disorder model. using A ATOM 1757 OG ASER 217 -21.166 -15.868 15.011 0.58 18.24 O Unresolved disorder model. using A ATOM 1758 OG BSER 217 -20.680 -16.479 13.132 0.42 26.71 O Unresolved disorder model. using A ATOM 1776 CB ASER 220 -14.875 -20.277 6.668 0.47 16.57 C Unresolved disorder model. using A ATOM 1777 CB BSER 220 -14.795 -20.271 6.678 0.53 17.10 C Unresolved disorder model. using A ATOM 1778 OG ASER 220 -13.541 -20.621 6.370 0.47 18.97 O Unresolved disorder model. using A ATOM 1779 OG BSER 220 -15.705 -20.826 5.744 0.53 17.56 O Chain identifier should be blank not A: ATOM 2126 CU CU A 688 10.693 5.812 9.935 0.52 19.35 CU Unknown residue CU: ATOM 2126 CU CU 688 10.693 5.812 9.935 0.52 19.35 CU Chain identifier should be blank not A: ATOM 2125 ZN ZN A 689 -6.722 -1.516 15.526 1.00 5.28 ZN 1